These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 32434398)

  • 1. Glucocorticoids in rheumatoid arthritis: the silent companion in the therapeutic strategy.
    Berardicurti O; Ruscitti P; Pavlych V; Conforti A; Giacomelli R; Cipriani P
    Expert Rev Clin Pharmacol; 2020 Jun; 13(6):593-604. PubMed ID: 32434398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current evidence for the management of rheumatoid arthritis with glucocorticoids: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis.
    Gorter SL; Bijlsma JW; Cutolo M; Gomez-Reino J; Kouloumas M; Smolen JS; Landewé R
    Ann Rheum Dis; 2010 Jun; 69(6):1010-4. PubMed ID: 20448288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucocorticoids in rheumatoid arthritis: current status and future studies.
    Hua C; Buttgereit F; Combe B
    RMD Open; 2020 Jan; 6(1):. PubMed ID: 31958273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of glucocorticoids, conventional and targeted synthetic disease-modifying antirheumatic drugs: a systematic literature review informing the 2016 update of the EULAR recommendations for the management of rheumatoid arthritis.
    Chatzidionysiou K; Emamikia S; Nam J; Ramiro S; Smolen J; van der Heijde D; Dougados M; Bijlsma J; Burmester G; Scholte M; van Vollenhoven R; Landewé R
    Ann Rheum Dis; 2017 Jun; 76(6):1102-1107. PubMed ID: 28356243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose corticosteroids and disease modifying drugs in patients with rheumatoid arthritis.
    Malysheva O; Baerwald CG
    Clin Exp Rheumatol; 2011; 29(5 Suppl 68):S113-5. PubMed ID: 22018195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of repository corticotropin injection as an adjunctive therapy for the treatment of rheumatoid arthritis.
    Fleischmann R; Furst DE
    Expert Opin Drug Saf; 2020 Aug; 19(8):935-944. PubMed ID: 32497440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. To treat or not to treat rheumatoid arthritis with glucocorticoids? A reheated debate.
    Cutolo M; Shoenfeld Y; Bogdanos DP; Gotelli E; Salvato M; Gunkl-Tóth L; Nagy G
    Autoimmun Rev; 2024 Jan; 23(1):103437. PubMed ID: 37652398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Harm, benefit and costs associated with low-dose glucocorticoids added to the treatment strategies for rheumatoid arthritis in elderly patients (GLORIA trial): study protocol for a randomised controlled trial.
    Hartman L; Rasch LA; Klausch T; Bijlsma HWJ; Christensen R; Smulders YM; Ralston SH; Buttgereit F; Cutolo M; Da Silva JAP; Opris D; Rovenský J; Szamosi S; Middelink LM; Lems WF; Boers M
    Trials; 2018 Jan; 19(1):67. PubMed ID: 29370811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucocorticoid safety for treating rheumatoid arthritis.
    Rasch LA; Bultink IE; van Tuyl LH; Lems WF
    Expert Opin Drug Saf; 2015 Jun; 14(6):839-44. PubMed ID: 25802019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An updated review of glucocorticoid-related adverse events in patients with rheumatoid arthritis.
    Luís M; Freitas J; Costa F; Buttgereit F; Boers M; Jap DS; Santiago T
    Expert Opin Drug Saf; 2019 Jul; 18(7):581-590. PubMed ID: 31056959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of low-dose glucocorticoids for rheumatoid arthritis in the biologic era.
    Caporali R; Scirè CA; Todoerti M; Montecucco C
    Clin Exp Rheumatol; 2013; 31(4 Suppl 78):S9-13. PubMed ID: 24129129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-Dose Glucocorticoids in Older Patients with Rheumatoid Arthritis: What Does the Evidence Say?
    Sugihara T; Tanaka E; Matsui T
    Drugs Aging; 2024 Aug; 41(8):641-652. PubMed ID: 39066877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucocorticoid use in rheumatoid arthritis: benefits, mechanisms, and risks.
    Townsend HB; Saag KG
    Clin Exp Rheumatol; 2004; 22(5 Suppl 35):S77-82. PubMed ID: 15552519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy, duration of use and safety of glucocorticoids: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis.
    Bergstra SA; Sepriano A; Kerschbaumer A; van der Heijde D; Caporali R; Edwards CJ; Verschueren P; de Souza S; Pope JE; Takeuchi T; Hyrich KL; Winthrop KL; Aletaha D; Stamm TA; Schoones JW; Smolen JS; Landewé RBM
    Ann Rheum Dis; 2023 Jan; 82(1):81-94. PubMed ID: 36410794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In the era of disease-modifying antirheumatic drugs, how close are we to treating rheumatoid arthritis without the use of glucocorticoids?
    Yagiz B; Coskun BN; Pehlivan Y; Dalkilic E; Kiraz S; Yazisiz V; Kucuksahin O; Erden A; Kanitez NA; Kimyon G; Emmungil H; Bilge SY; Kasifoglu T; Bes C; Bolek EC; Bilgin E; Karatas A; Kelesoglu B; Ersozlu D; Gonullu EO; Mercan R; Yilmaz S; Karadag O; Akar S; Ertenli I; Kalyoncu U
    Rheumatol Int; 2021 Nov; 41(11):1915-1924. PubMed ID: 34226947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A dose of only 5 mg prednisolone daily retards radiographic progression in early rheumatoid arthritis - the Low-Dose Prednisolone Trial.
    Wassenberg S; Rau R; Zeidler H;
    Clin Exp Rheumatol; 2011; 29(5 Suppl 68):S68-72. PubMed ID: 22018187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What do we know about the safety of corticosteroids in rheumatoid arthritis?
    Ethgen O; de Lemos Esteves F; Bruyere O; Reginster JY
    Curr Med Res Opin; 2013 Sep; 29(9):1147-60. PubMed ID: 23790244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucocorticoids in rheumatoid arthritis: lessons from the Utrecht study.
    Jacobs JW; Bijlsma JW
    Clin Exp Rheumatol; 2011; 29(5 Suppl 68):S59-62. PubMed ID: 22018185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Glucocorticoid therapy in rheumatoid arthritis - pro].
    Pongratz G
    Dtsch Med Wochenschr; 2016 Oct; 141(22):1650. PubMed ID: 27824423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The supplementary therapeutic DMARD role of low-dose glucocorticoids in rheumatoid arthritis.
    Cutolo M; Spies CM; Buttgereit F; Paolino S; Pizzorni C
    Arthritis Res Ther; 2014 Nov; 16 Suppl 2(Suppl 2):S1. PubMed ID: 25608624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.